XML 15 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Consolidated Statements Of Operations      
Sales $ 29,520 $ 27,681 $ 23,660
Cost of sales 16,963 18,689 14,462
Gross profit 12,557 8,992 9,198
Other costs and expenses:      
Research and development 2,160 1,416 1,260
Professional services 1,484 1,016 1,835
Salaries and related costs 7,482 5,723 3,992
Selling, general and administrative 8,417 6,686 5,777
Total other costs and expenses 19,543 14,841 12,864
Loss from operations (6,986) (5,849) (3,666)
Interest expense, net $ (158) $ (151) (237)
Investor warrants issuance cost (664)
Fees associated with refinance (543)
Change in fair value of liabilities, net $ 1,799 $ (7,285) (842)
Total other income (expense), net 1,641 (7,436) (2,286)
Loss before income taxes (5,345) (13,285) (5,952)
Income tax expense (benefit) (25) (3,997) 1,613
Net loss (5,370) (17,282) (4,339)
Accretion on convertible preferred stock (222) $ (932) $ (39)
Gain on conversion of warrants and preferred shares, net $ 13,956
Deemed dividend on beneficial conversion feature $ (2,616)
Net income (loss) attributable to common shareholders $ 8,364 $ (18,214) $ (6,994)
Income (loss) per share      
Basic $ 0.34 $ (1.03) $ (0.4)
Diluted $ 0.24 $ (1.03) $ (0.4)
Weighted average number of shares outstanding- basic 24,333,000 17,756,000 17,760,000
Weighted average number of shares outstanding - dilutive 27,747,000 17,756,000 17,760,000